Cite
Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients.
MLA
Martino, Massimo, et al. “Efficacy of Biosimilar Granulocyte Colony-Stimulating Factor versus Originator Granulocyte Colony-Stimulating Factor in Peripheral Blood Stem Cell Mobilization in de Novo Multiple Myeloma Patients.” Cytotherapy (Elsevier Inc.), vol. 17, no. 10, Oct. 2015, pp. 1485–93. EBSCOhost, https://doi.org/10.1016/j.jcyt.2015.05.010.
APA
Martino, M., Moscato, T., Fedele, R., Recchia, A. G., Morabito, F., Neri, S., Gentile, M., Alati, C., Vincelli, I. D., Ronco, F., Piro, E., Molica, S., Penna, G., & Musolino, C. (2015). Efficacy of biosimilar granulocyte colony-stimulating factor versus originator granulocyte colony-stimulating factor in peripheral blood stem cell mobilization in de novo multiple myeloma patients. Cytotherapy (Elsevier Inc.), 17(10), 1485–1493. https://doi.org/10.1016/j.jcyt.2015.05.010
Chicago
Martino, Massimo, Tiziana Moscato, Roberta Fedele, Anna Grazia Recchia, Fortunato Morabito, Santo Neri, Massimo Gentile, et al. 2015. “Efficacy of Biosimilar Granulocyte Colony-Stimulating Factor versus Originator Granulocyte Colony-Stimulating Factor in Peripheral Blood Stem Cell Mobilization in de Novo Multiple Myeloma Patients.” Cytotherapy (Elsevier Inc.) 17 (10): 1485–93. doi:10.1016/j.jcyt.2015.05.010.